纳指生物科技ETF(513290)

动态评分: 5.70分

投资组合

报告日期 名称 比例
2024-06-30 Krystal Biotech Inc 0.54%
2024-06-30 BridgeBio Pharma Inc 0.49%
2024-06-30 CRISPR Therapeutics AG 0.48%
2024-06-30 Apellis Pharmaceuticals Inc 0.48%
2024-06-30 Nuvalent Inc-A 0.47%
2024-06-30 ImmunityBio Inc 0.45%
2024-06-30 阿尔凯默斯 0.42%
2024-06-30 Avidity Biosciences Inc 0.41%
2024-06-30 Merus NV 0.41%
2024-06-30 Immunovant Inc 0.4%
2024-06-30 Axsome Therapeutics Inc 0.4%
2024-06-30 Legend Biotech Corp ADR 0.38%
2024-06-30 Guardant Health Inc 0.37%
2024-06-30 Crinetics Pharmaceuticals Inc 0.37%
2024-06-30 Dyne Therapeutics Inc 0.36%
2024-06-30 Ultragenyx Pharmaceutical Inc 0.35%
2024-06-30 Arrowhead Pharmaceuticals Inc 0.34%
2024-06-30 Denali Therapeutics Inc 0.34%
2024-06-30 爱美医疗 0.31%
2024-06-30 Arcellx Inc 0.31%

投资模拟

公告&资料